Epirubicin/paclitaxel/carboplatin (TEC) versus paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO Stages IIB-IV. Interim results of an AGO-GINECO intergroup phase III trial. - du Bois,A.; Weber,B.; Pfisterer,J.; Groupil,A.; Wagner,U.; Barats,J.; Olbrich,S.; Mousseau,M.; Nitz,U.; Meden,H. (Proc Am Soc Clin Oncol, 2001)